Nyxoah S.A. (NASDAQ:NYXH) Sees Large Drop in Short Interest

Nyxoah S.A. (NASDAQ:NYXH - Get Free Report) saw a large drop in short interest in March. As of March 15th, there was short interest totalling 63,700 shares, a drop of 36.4% from the February 28th total of 100,200 shares. Based on an average daily volume of 47,400 shares, the short-interest ratio is presently 1.3 days. Currently, 0.4% of the company's stock are short sold.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of NYXH. LPL Financial LLC purchased a new position in Nyxoah in the 4th quarter valued at $102,000. Walleye Capital LLC raised its holdings in Nyxoah by 23.9% during the fourth quarter. Walleye Capital LLC now owns 14,831 shares of the company's stock worth $119,000 after purchasing an additional 2,862 shares in the last quarter. Ameriprise Financial Inc. acquired a new stake in Nyxoah in the fourth quarter valued at about $135,000. Geode Capital Management LLC boosted its holdings in Nyxoah by 19.4% in the 4th quarter. Geode Capital Management LLC now owns 17,100 shares of the company's stock valued at $137,000 after purchasing an additional 2,774 shares in the last quarter. Finally, Kovack Advisors Inc. increased its position in Nyxoah by 100.0% during the 4th quarter. Kovack Advisors Inc. now owns 20,000 shares of the company's stock worth $160,000 after purchasing an additional 10,000 shares during the period.

Analyst Ratings Changes

Several analysts recently weighed in on NYXH shares. Stifel Nicolaus reduced their target price on shares of Nyxoah from $16.00 to $15.00 and set a "buy" rating on the stock in a report on Friday, March 14th. HC Wainwright decreased their price objective on shares of Nyxoah from $17.00 to $15.00 and set a "buy" rating for the company in a research report on Wednesday, March 26th.

Remove Ads

Nyxoah Stock Performance

NYXH stock traded down $0.37 on Wednesday, hitting $6.50. The company's stock had a trading volume of 69,411 shares, compared to its average volume of 47,152. The stock has a market cap of $221.39 million, a price-to-earnings ratio of -3.48 and a beta of 1.42. The firm has a 50 day moving average of $10.19 and a two-hundred day moving average of $9.35. The company has a current ratio of 5.28, a quick ratio of 4.95 and a debt-to-equity ratio of 0.21. Nyxoah has a 1 year low of $6.26 and a 1 year high of $13.50.

Nyxoah (NASDAQ:NYXH - Get Free Report) last announced its earnings results on Thursday, March 13th. The company reported ($0.49) EPS for the quarter, missing analysts' consensus estimates of ($0.46) by ($0.03). The business had revenue of $1.35 million during the quarter, compared to analysts' expectations of $2.02 million. Nyxoah had a negative net margin of 1,043.93% and a negative return on equity of 51.68%. Equities analysts predict that Nyxoah will post -1.91 EPS for the current fiscal year.

Nyxoah Company Profile

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.